Evidence map›Paper›PMID 32380768›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Pathways of 4-Hydroxy-2-Nonenal Detoxification in a Human Astrocytoma Cell Line.

Eleonora Peroni, Viola Scali, Francesco Balestri, Mario Cappiello, Umberto Mura, Antonella Del Corso, Roberta Moschini

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Cellular Oxidative Stress.Antioxidants (Basel, Switzerland) · 2021
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Eleonora PeroniEcoverde SpA, via IV Novembre, 55016 Porcari (LU), Italy.
Viola ScaliDepartment of Biology, Biochemistry Unit, University of Pisa, via S. Zeno, 51, 56123 Pisa, Italy.
Francesco BalestriDepartment of Biology, Biochemistry Unit, University of Pisa, via S. Zeno, 51, 56123 Pisa, Italy.
Mario CappielloDepartment of Biology, Biochemistry Unit, University of Pisa, via S. Zeno, 51, 56123 Pisa, Italy.
Umberto MuraDepartment of Biology, Biochemistry Unit, University of Pisa, via S. Zeno, 51, 56123 Pisa, Italy.
Antonella Del CorsoDepartment of Biology, Biochemistry Unit, University of Pisa, via S. Zeno, 51, 56123 Pisa, Italy.
Roberta MoschiniDepartment of Biology, Biochemistry Unit, University of Pisa, via S. Zeno, 51, 56123 Pisa, Italy.
University of Pisa · IT

Funding

Università di Pisa Fondi di Ateneo
6 · The paper itself

Abstract

One of the consequences of the increased level of oxidative stress that often characterizes the cancer cell environment is the abnormal generation of lipid peroxidation products, above all 4-hydroxynonenal. The contribution of this aldehyde to the pathogenesis of several diseases is well known. In this study, we characterized the ADF astrocytoma cell line both in terms of its pattern of enzymatic activities devoted to 4-hydroxynonenal removal and its resistance to oxidative stress induced by exposure to hydrogen peroxide. A comparison with lens cell lines, which, due to the ocular function, are normally exposed to oxidative conditions is reported. Our results show that, overall, ADF cells counteract oxidative stress conditions better than normal cells, thus confirming the redox adaptation demonstrated for several cancer cells. In addition, the markedly high level of NADP

Indexed as

3-glutathionyl-4-hydroxynonanal4-hydroxy-2-nonenalastrocytoma cells

Identifiers

PMID32380768
PMCPMC7278743
OpenAlexW3022762329

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.